BAY43-9006 - Phase II Study in Non-Small Cell Lung Carcinoma (NSCLC)

Clinical trial NCT00101413 · COMPLETED

Trial details

NCT number: NCT00101413
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Carcinoma, Non-Small Cell Lung

Start date: 2004-04-01
Primary completion: 2005-06-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.